Clonal hematopoiesis of indeterminate potential (CHIP) in cerebromicrovascular aging: implications for vascular contributions to cognitive impairment and dementia (VCID)

Documenti analoghi

• Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
  di: Mónika Fekete, et al.
  Pubblicazione: (2025)
• Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation
  di: Ungvari, Zoltan, et al.
  Pubblicazione: (2019)
• Genomic instability and genetic heterogeneity in aging: insights from clonal hematopoiesis (CHIP), monoclonal gammopathy (MGUS), and monoclonal B-cell lymphocytosis (MBL)
  di: Attila Kállai, et al.
  Pubblicazione: (2024)
• Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging
  di: Tarantini, Stefano, et al.
  Pubblicazione: (2019)
• Cerebromicrovascular senescence in vascular cognitive impairment: does accelerated microvascular aging accompany atherosclerosis?
  di: Anna Ungvari, et al.
  Pubblicazione: (2025)